Regulation of Vascular Redox State by Thioredoxin

硫氧还蛋白对血管氧化还原状态的调节

基本信息

  • 批准号:
    7029361
  • 负责人:
  • 金额:
    $ 35.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

Thioredoxin is a powerful scavenger of reactive oxygen species. Thioredoxin-interacting protein (Txnip; also known as VDUP1 or Vitamin D3 Up-regulated Protein 1) binds to thioredoxin and is now known to be an important inhibitor of thioredoxin activity. We have previously shown that Txnip is itself a redox-sensitive gene with a protein product that impairs cell survival. Furthermore, Txnip overexpression blocks cellular growth responses, and growth factor signals such as PDGF require degradation of Txnip in order to allow thioredoxinmediated transcriptional activity. Thus, compelling evidence has now emerged that Txnip, an obscure orphan gene product only a few years ago, is a critical regulator of diverse signaling events due to its direct inhibition of thioredoxin activity. Because intracellular thioredoxin levels tend to be constant, Txnip may therefore be a key mechanism for controlling intracellular redox state. Reactive oxygen species participate in many stages of atherosclerosis. Here we present preliminary data on the potential importance of Thioredoxin/Txnip in vascular disease and describe its potential role in accelerating atherosclerosis. An intriguing new finding is that while many stimuli suppress Txnip and thus increase thioredoxin activity, glucose robustly induces Txnip and inhibits thioredoxin activity both in vitro and in vivo. We propose exploration of the central hypothesis that regulation of Txnip impairs vascular thioredoxin activity, leading to increased oxidative stress and promoting atherosclerosis. Because glucose induces Txnip, these experiments have particular relevance to diabetic vascular disease. We describe three hypothesis-driven Aims that will explore the role of Txnip in vascular pathophysiology in vitro and in vivo. The Aims are: Aim 1. To test the hypothesis that the induction of Txnip by glucose promotes a pro-apoptotic state in vascular cells through blockade of thioredoxin's antioxidant function. Aim 2. To test the hypothesis that Txnip regulates redox state in diabetic arteries in mice using tissue-specific targeted gene deletion approaches. Aim 3. To test the hypothesis that regulation of Txnip participates in the promotion of atherosclerosis.
硫氧还蛋白是一种强大的活性氧清除剂。硫氧还蛋白相互作用蛋白

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard E. Lee其他文献

EVALUATION OF GLYCEROL AND DIMETHYL SULFOXIDE FOR THE CRYOPRESERVATION OF SPERMATOZOA FROM THE WOOD FROG (RANA SYLVATICA)
甘油和二甲基亚砜对林蛙 (RANA SYLVATICA) 精子冷冻保存的评价
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. A. Mugnano;J. P. Costanzo;Sara G. Beesley;Richard E. Lee
  • 通讯作者:
    Richard E. Lee
Carotid blood flow and pathogenesis of cerebral ischaemia
颈动脉血流与脑缺血的发病机制
The Bulbar Conjunctival Vascular Bed in Normal Pregnancy
  • DOI:
    10.1016/s0002-9378(16)38683-5
  • 发表时间:
    1953-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert Landesman;Gordon Douglas;Georgene Dreishpoon;Richard E. Lee
  • 通讯作者:
    Richard E. Lee
Ultrastructural effects of lethal freezing on brain, muscle and Malpighian tubules from freeze-tolerant larvae of the gall fly, Eurosta solidaginis.
致命冷冻对耐冻胆蝇幼虫脑、肌肉和马氏小管的超微结构影响。
  • DOI:
    10.1016/s0022-1910(96)00073-x
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Stephen D Collins;A. Allenspach;Richard E. Lee
  • 通讯作者:
    Richard E. Lee
An approach to combinatorial library generation of galactofuranose mimics as potential inhibitors of mycobacterial cell wall biosynthesis: Synthesis of a peptidomimetic of uridine 5′-diphosphogalactofuranose (UDP-Galf)
呋喃半乳糖模拟物作为分枝杆菌细胞壁生物合成潜在抑制剂的组合文库生成方法:尿苷 5′-二磷酸半乳呋喃糖肽模拟物的合成 (UDP-Galf)
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richard E. Lee;Martin D. Smith;L. Pickering;G. Fleet
  • 通讯作者:
    G. Fleet

Richard E. Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard E. Lee', 18)}}的其他基金

Spectinomycin analogs for NTM infections
用于 NTM 感染的壮观霉素类似物
  • 批准号:
    10471892
  • 财政年份:
    2020
  • 资助金额:
    $ 35.11万
  • 项目类别:
Spectinomycin analogs for NTM infections
用于 NTM 感染的壮观霉素类似物
  • 批准号:
    10265604
  • 财政年份:
    2020
  • 资助金额:
    $ 35.11万
  • 项目类别:
Spectinomycin analogs for NTM infections
用于 NTM 感染的壮观霉素类似物
  • 批准号:
    10673801
  • 财政年份:
    2020
  • 资助金额:
    $ 35.11万
  • 项目类别:
Training in the Design and Development of Infectious Disease Therapeutics
传染病治疗药物设计和开发培训
  • 批准号:
    10617855
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
Training in the Design and Development of Infectious Disease Therapeutics
传染病治疗药物设计和开发培训
  • 批准号:
    10447715
  • 财政年份:
    2015
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of Aminospectinomycins for Biodefense
用于生物防御的氨基大观霉素的开发
  • 批准号:
    8860114
  • 财政年份:
    2014
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of Aminospectinomycins for Biodefense
用于生物防御的氨基大观霉素的开发
  • 批准号:
    9291410
  • 财政年份:
    2014
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of Aminospectinomycins for Biodefense
用于生物防御的氨基大观霉素的开发
  • 批准号:
    8693411
  • 财政年份:
    2014
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of novel proteins synthesis inhibitors for MDR tuberculosis
耐多药结核病新型蛋白质合成抑制剂的开发
  • 批准号:
    8305156
  • 财政年份:
    2010
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of novel proteins synthesis inhibitors for MDR tuberculosis
耐多药结核病新型蛋白质合成抑制剂的开发
  • 批准号:
    7989056
  • 财政年份:
    2010
  • 资助金额:
    $ 35.11万
  • 项目类别:

相似海外基金

Investigating the blood glucose lowering effect of exogenous ketone ingestion in people with type 2 diabetes
研究外源性酮摄入对 2 型糖尿病患者的降血糖作用
  • 批准号:
    MR/Y008804/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.11万
  • 项目类别:
    Research Grant
G6PC Enzymology, Structure, Function and Role in the Regulation of Fasting Blood Glucose
G6PC 酶学、结构、功能及其在空腹血糖调节中的作用
  • 批准号:
    10584866
  • 财政年份:
    2023
  • 资助金额:
    $ 35.11万
  • 项目类别:
Separate extraction of spatial features related to blood glucose level variation from multi-wavelength spectral face images
从多波长光谱人脸图像中单独提取与血糖水平变化相关的空间特征
  • 批准号:
    23K17258
  • 财政年份:
    2023
  • 资助金额:
    $ 35.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Glucowear: A non-invasive, wearable, real time continuous blood glucose monitoring sensor
Glucowear:一种非侵入式、可穿戴式、实时连续血糖监测传感器
  • 批准号:
    10068829
  • 财政年份:
    2023
  • 资助金额:
    $ 35.11万
  • 项目类别:
    EU-Funded
A Serious Game to Teach Early School-Aged Children Blood Glucose Monitoring
教早期学龄儿童血糖监测的严肃游戏
  • 批准号:
    571894-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
    University Undergraduate Student Research Awards
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System
使用基于人工智能的新型血糖控制系统演示重症监护病房中血糖闭环控制的可行性
  • 批准号:
    10482483
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
GLUMON:Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing
GLUMON:使用非侵入性光声传感的下一代血糖监测
  • 批准号:
    10032702
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
    EU-Funded
Portable Thermophotonic Biosensor Development for in-vivo Blood Glucose Monitoring
用于体内血糖监测的便携式热光子生物传感器的开发
  • 批准号:
    572588-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
    University Undergraduate Student Research Awards
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System
使用基于人工智能的新型血糖控制系统演示重症监护病房中血糖闭环控制的可行性
  • 批准号:
    10631190
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
Development of perioperative blood glucose control methods for prevention of postoperative vascular endothelial glycocalyx disorders
开发围手术期血糖控制方法以预防术后血管内皮糖萼疾病
  • 批准号:
    22K09093
  • 财政年份:
    2022
  • 资助金额:
    $ 35.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了